Chao Hong Hu
Net worth: 96 M $ as of 2024-04-29
Career history of Chao Hong Hu
Former positions of Chao Hong Hu
| Companies | Position | Start | End |
|---|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Director/Board Member | 2020-05-15 | 2024-01-30 |
| Chief Executive Officer | 2020-05-15 | 2024-01-30 | |
| SEAGEN INC. | Corporate Officer/Principal | 2007-05-31 | 2013-09-30 |
| GSK PLC | Corporate Officer/Principal | 2005-12-31 | 2007-04-30 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - | 2004-12-31 |
Shanghai Miracogen, Inc.
 Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Chief Executive Officer | 2013-12-31 | - |
| Chairman | 2013-12-31 | - | |
| Founder | 2013-12-31 | - |
Training of Chao Hong Hu
| Wuhan University | Undergraduate Degree |
Statistics
International
| China | 4 |
| United States | 2 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| LEPU BIOPHARMA CO., LTD. | Health Technology |
| GSK PLC | Health Technology |
| Private companies | 3 |
|---|---|
Shanghai Miracogen, Inc.
Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Chao Hong Hu
- Experience
